{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:03:45Z","timestamp":1789628625233,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.healun.2014.01.853","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T16:50:49Z","timestamp":1390495849000},"page":"521-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: Clinical associations"],"prefix":"10.1016","volume":"33","author":[{"given":"Neeraj","family":"Dhaun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Vachiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Benza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Naeije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie-Ju","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Teal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2014.01.853_bib1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.99.13368299","article-title":"Hyperuricaemia in patients with right or left heart failure","volume":"13","author":"Hoeper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2014.01.853_bib2","first-page":"162","article-title":"Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan","volume":"39","author":"Chen","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.healun.2014.01.853_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.160.2.9812078","article-title":"Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension","volume":"160","author":"Nagaya","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2014.01.853_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.117.1.19","article-title":"Hyperuricemia in severe pulmonary hypertension","volume":"117","author":"Voelkel","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.healun.2014.01.853_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/rmed.2003.1440","article-title":"Hyperuricemia as a prognostic factor in pulmonary arterial hypertension","volume":"97","author":"Bendayan","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.healun.2014.01.853_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1378\/chest.10-3331","article-title":"Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension","volume":"141","author":"Sun","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.healun.2014.01.853_bib7","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2014.01.853_bib8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study","volume":"164","author":"Niskanen","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.healun.2014.01.853_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","article-title":"Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort","volume":"44","author":"Iseki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.healun.2014.01.853_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.healun.2014.01.853_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000105142","article-title":"The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease","volume":"27","author":"Talaat","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.healun.2014.01.853_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","article-title":"Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial","volume":"58","author":"Miao","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.healun.2014.01.853_bib13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2014.01.853_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2005121256","article-title":"The endothelin system and its antagonism in chronic kidney disease","volume":"17","author":"Dhaun","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2014.01.853_bib15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2014.01.853_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tips.2007.10.002","article-title":"Selective and mixed endothelin receptor antagonism in cardiovascular disease","volume":"28","author":"Dhaun","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.healun.2014.01.853_bib17","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","article-title":"Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan","volume":"47","author":"Barst","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2014.01.853_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1378\/chest.07-0767","article-title":"Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival","volume":"134","author":"Benza","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.healun.2014.01.853_bib19","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1681\/ASN.2008010080","article-title":"Elevated uric acid increases the risk for kidney disease","volume":"19","author":"Obermayr","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2014.01.853_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1253\/circj.67.375","article-title":"Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension","volume":"67","author":"Ono","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.healun.2014.01.853_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00296-010-1557-4","article-title":"Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study","volume":"31","author":"Dimitroulas","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.healun.2014.01.853_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1536\/ihj.48.523","article-title":"Serum uric acid as a prognostic predictor in pulmonary arterial hypertension with connective tissue disease","volume":"48","author":"Njaman","year":"2007","journal-title":"Int Heart J"},{"key":"10.1016\/j.healun.2014.01.853_bib23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2014.01.853_bib24","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2014.01.853_bib25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11255-007-9253-3","article-title":"Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions","volume":"39","author":"Kanbay","year":"2007","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.healun.2014.01.853_bib26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.108.113068","article-title":"Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis","volume":"52","author":"Raichlin","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.healun.2014.01.853_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4414\/smw.2007.11670","volume":"137","author":"Ulrich","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.healun.2014.01.853_bib28","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2014.01.853_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2045-8932.94819","article-title":"Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension","volume":"2","author":"Condliffe","year":"2012","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2014.01.853_bib30","first-page":"A4864","article-title":"Prevalence of chronic kidney disease in patients with pulmonary arterial hypertension","volume":"179","author":"Cedergreen","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2014.01.853_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1378\/chest.06-1758","article-title":"N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension","volume":"131","author":"Leuchte","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.healun.2014.01.853_bib32","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/CIRCULATIONAHA.107.719500","article-title":"Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension","volume":"117","author":"Shah","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2014.01.853_bib33","first-page":"44","article-title":"Endothelial function in patients with arterial hypertension and impaired uric acid metabolism [in Russian]","author":"Lebedeva","year":"2010","journal-title":"Vestn Ross Akad Med Nauk"},{"key":"10.1016\/j.healun.2014.01.853_bib34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.phrs.2011.03.003","article-title":"The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension","volume":"63","author":"Shao","year":"2011","journal-title":"Pharmacol Res"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249814008675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249814008675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:27:00Z","timestamp":1760948820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249814008675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1053249814008675"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2014.01.853","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: Clinical associations","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2014.01.853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}